HealthObs is an integrated (Java-based) environment targeting the seamless integration and intelligent processing of distributed and heterogeneous clinical and genomic data. Via the appropriate customization of standard medical and genomic data-models HealthObs achieves the semantic homogenization of remote clinical and gene-expression records, and their uniform XML-based representation. The system utilizes data-mining techniques (association rules mining) that operate on top of query-specific XML documents. Application of HealthObs on a real world breast-cancer clinico-genomic study demonstrates the utility and efficiency of the approach.
Introduction
As the number of electronic clinical records and respective data repositories increases, the seamless integration of the respective data repositories coupled with knowledge discovery operations offer the potential for the automated discovery of valuable clinical knowledge. Furthermore, the completion of the human genome drives us to the post-genomics era. In this environment the newly raised scientific and technological challenges push for trans-disciplinary team science and translational research. As it is noted by J. Grimson: '… Patient empowerment fuelled by the Internet coupled with post genomics will ultimately lead to a health system which focuses more on promoting wellness rather than on treating illness … Such a system must be centred on the patient (citizen) and their health status and management. The existence of a longitudinal Electronic Health Care Record is fundamental to bringing about this paradigm shift in the healthcare system' [11] .
gene-expression datasets in order to induce indicative clusters of genes, called Metagenes. Clustering is performed with discr_k-means -a revision of the k-means algorithm that primarily identifies clusters of co-regulated binary-valued genes. To overcome the error-prone variance of gene-expression levels, gene-expression values are discretized (following a data pre-processing discretization step) into two nominal values: 'low' and 'high'. Putting it in more molecular biology terms, the 'low' and 'high' gene-expression levels correspond to 'DOWN'-and 'UP'-regulated status of the genes, respectively. The discr_k-means algorithm resembles similar approaches presented in [17] and [20] ; for a more detailed description of the discr_k-means algorithm, please refer to [3, 14] . After convergence of discr_k-means, each metagene is linked with respective (patient) samples and obeys a special characteristic: all of its genes exhibit a 'strong' gene-expression profile for all of its linked samples, i.e., exhibit solely 'high' (or, solely 'low') expression levels. Then, the quest is forwarded towards the identification of associations between metagenes and specific clinico-histopathological profiles.
In this paper we focus on the presentation and utilization of an association rule mining system, called HealthObs [5, 8, 12] , to discover interesting and indicative association between patients' clinical and genomic gene-expression profiles, i.e., the metagenes. In the next section we present the architectural specifics of HealthObs. Section 3 presents the basic HealthObs operations and functionality. In section 4 we present results of using HealthObs on a real world breast-cancer study. In the last section we conclude and present hints for further research and development. 
Architectural and Operational Set-Up of HealthObs
HealthObs is an integrated system that offers: (i) semantic homogenization of respective distributed and heterogeneous clinical and genomic data sources, (ii) uniform representation of the respective data-items as realized by standard clinical and microarray data-models, and (iii) intelligent processing of XML-formatted documents enabled by the discovery of interesting clinical associations implemented by the customization of association rules mining (ARM) techniques [9, 18] . HealthObs offers a population-oriented view on the distributed patients' clinicogenomic information as recorded in respective clinical and genomic/microarray information systems.
Association rules mining [9, 18] is among the most advanced and interesting methods for finding interesting patterns and indicative trends in data. The definition of an ARM problem has as follows: Let I = {i 1 Given a set of transactions D, the ARM problem is to discover the associations that have support and confidence values higher that the user specified minimum support, and minimum confidence levels, respectively.
An outline of the reference architecture underlying HealthObs is shown in Figure  1 (above) where, the basic operational modules of the system are also shown. Central to the architecture is a single data-enriched XML file which contains information and data from distributed and heterogeneous clinical and genomic information systems. Accumulation of data and their XML formatting are performed off-line. To this end, the Mediator infrastructure [2] is utilized in order to mediate and query federated clinical and genomic information sources and recall the relevant query-specific data items. For each query, and with the aid of custom made filtering and formatting operations, the respective query-specific XML file is created. HealthObs initiates and base its operations on such data-enriched XML files.
Basic Operations and Functionality of HealthObs
Query formulation supports the representation of the inquiry presented to the system. For instance, a user may decide to investigate and assess the confidence of associations between a focused number of clinical and genomic features. For example, between histological/biochemical-tests, such as 'ER' (Estrogen Receptor) status and prognostic features, such as patients' 'METASTASIS' status, on one hand, and genomic features, e,g., 'UP'/'DOWN'-regulated status of specific genes, on the other. In Figure 2 , the system's feature-selection/focusing interface is shown. The features to be selected correspond to the instance elements being present in the data-enriched XML file to process.
In Figure 2 note the unique characteristic of HealthObs that relate to the specification of the desired form of 'focused' association rules to induce: rules to induce: (a) if the user only check-tick ( ) a feature, then this feature may or maynot be present in the rule, i.e., not-obligatory feature, (b) if the user not only checks a feature but post an 'IF' ( , e.g., ER, MG33g9c19) or a 'THEN' ( , e.g., METASTASIS) tick on it then, the presence of the feature in the association rules is obligatory in the 'IF' or, 'THEN' part of the rule, respectively. 
Semantic Homogenization
Upon presentation of the inquiry and selection of the respective query features, HealthObs activates the Common Term Reference Service (CTRS) component. CTRS support the placement of the query in context of domain's semantics, e.g., involved medical and genomic nomenclatures and data-models. The SNOMED/CT, ICD and LOINC medical ontologies and nomenclatures (see section 1), as well as the 'Minimum Information About Microarray Experiments' (MIAME, http://www.mged.org/ Workgroups/MIAME/miame.html) microarray/gene-expression data-models are utilized. CTRS incorporates (user's) specifications for the semantics of the domain (e.g., valid reference-ranges for lab findings, enabled by the transformation of numerical values to qualitative equivalents or, assignment of continuous gene-expression values to qualitative ones, e.g., into 'high'/'low' expression levels). Activation of the CTRS component results to the creation of an intermediate XML domain semantics and query specific schema ('XMLdsq' tree in Figure 1 ). XMLdsq is a restriction of the given DTD grammar and helps to: (i) focus the inquiry on the user selected features, and (ii) semantically homogenize the content of the data-enriched XML file. For the editing of the domainsemantics file, and its customization to different domains, we have also developed a special tool, the 'Domain Editor', made operational within the HealthObs environment (for detail see [8] ).
The Prefix-Tree Structure
The recalled query-specific clinical data are kept in the corresponding data-rich XML-documents, and the implemented ARM operations are performed exclusively on top of these documents. The implemented ARM operations rely on the principles of the Apriori algorithm [18] . Adaptation of Apriori-like functionality on top of XML structures is based on a specially devised XML parser enabled by objectoriented search operations. Following RDF/XML techniques, the parser reads/scans the XML document in order to identify composite/atomic observations and homogenize their content (with CCTR service).
In the core of the ARM process is the identification of all frequent itemsets. Usually this is achieved by multiple-scans of the data (in our case, of the XMLdocument). Thus information-space search operations should be efficient. To enhance on efficiency we rely on a prefix-tree -a special tree-like data structure, that passes the data only once, the prefix-tree [1, 19] . A prefix-tree structure makes no distinction between internal and leaf nodes. In this structure, nodes do not contain sets, but only information about sets (e.g. counters). Each edge in the tree is labelled with an item, and each node contains the information for the set of items labelling the edges of its path to the root. Prefix-trees store both frequent sets and candidate sets in the same tree.
HealthObs in Practice
The utility of HealthObs system was assessed byn applying it on a real-world breastcancer study [13] . This study profiles the expression of ~24800 genes on 78 breastcancer patients. The aim was to reveal (potentially) interesting and indicative individualized (i.e., target-population oriented) clinico-genomic profiles.
Characterization and classification of a disease, and prediction of respective patients' clinical outcome could be performed with reference either to solely clinicohistopathological patient profiles (CHPPs or, clinical phenotypes) -the clinical classification of the disease or, to solely genomic (i.e., microarray gene-expression) patient profiles (GEPPs or, genomic phenotypes) -provided that specific and reliable gene-markers are available. If this presents the decision-making track in the course of a clinico-genomic research trial, the most challenging task is the knowledge discovery track which works in a more-or-less inverse way. That is, starting from observable clinico-histopathological disease states the quest targets the identification of respective molecular signatures or, gene-markers able to discriminate between the different disease states.
Based on the central-dogma of molecular biology, CHPPs could be fully 'shaped' and causally determinable by respective GEPPs. In this setting, the quest is forwarded towards the following target: "which clinico-histopathology phenotypes relate and how with which gene-expression phenotypes?" Such a discovery-driven scenario falls into the individualized medicine context -GEPPs may be utilised to 'screen' respective CHPPs, to refine the clinical decision-making process, and finally identify specific patients groups (i.e., cohorts) as more suitable for specific clinical follow-up procedures. The whole endeavour aims to the identification of abductive and inductive inferential 'rules'.
As we have already mentioned (see section 1) we have designed and developed a Mediation infrastructure to recall patients' clinical and gene-expression data from respective clinical and microarray information systems [2] . With the utilization of a clustering operation -realized by the customization of k-means clustering technique on categorical data [3, 14] , we induce indicative clusters of genes, called Metagenes that meet a special characteristic: all of its genes exhibit a 'strong' gene-expression profile for all of its linked samples, i.e., exhibit solely 'high'/'UP'-regulated or, solely 'low'/'DOWN'-regulated expression levels. For example, with 'MG39g7c20=DOWN' we denote a cluster with id=39 ('MG39'), which includes 7 genes ('g7') and covers 20 cases ('c20'), and for all 20 cases all the respective genes exhibit a DOWN value (i.e., are down-regulated or, exhibit 'low' expression levels). A total of 22 such metagenes were induced when the following genes' prefiltering was applied: p-value ≤ 0.01 and a 2-fold difference in at least 5 samples (similar filtering was applied in the original reference study [13] ).
HealthObs was called to induce associations between the induced metagenevalues and respective clinical feature-values for the available set of 78 patient samples. The target clinical feature was set to 'METASTASIS' (in the reference breast-cancer study metastasis is considered as 'YES' ('good') or 'NO' ('bad') if it occurred in less than five years or not, respectively. A total of 32 association rules were induced (22 concluding to 'METASTASIS=NO', and 10 to 'METASTASIS=YES') when the following parameters were applied: min-sup = 13% (i.e., at least 10 samples), and min-conf = 60%. By visual inspection of the rules (offered by HealthObs's graphical interface), we were able to identify some interesting associations with potential clinical decision-making value.
For example, one of the rules is: ER=pos ⇒ METASTASIS=NO Confidence=63%, Support: 63% = 49 cases Another, related with the above, rule that was induced is:
ER=pos & MG39g7c20=DOWN ⇒ METASTASIS=NO Confidence=100%, Support: 13% = 10 cases ER (Estrogen Receptor) factor possesses a distinct prognostic value for breastcancer patients. In a 'positive' ('pos') ER state the prognosis is considered as good (i.e., no metastasis). The first rule, above, validates partially this, i.e., it is true in 63% of the cases. With the inclusion of gene-expression information and knowledge the evidence of a good prognosis could be improved. This is what the second rule states and suggests: with the knowledge that all genes in metagene MG39g7c20 are in 'DOWN'-regulated state then, the good prognosis is definite (i.e., 100% confident). Note that the second rule covers just 10 cases, less than the 49 cases (~ 9%) covered by the first rule. This could be considered as an approach to individualization of prognosis in the context of a molecular medicine environment. There are other association rules induced by HealthObs that cover other cases. For example the rule below engages two metagenes, is also 100% confident, and covers another subpopulation of 7 cases:
ER=pos & MG9g6c22=UP & MG38g4c28=UP ⇒ METASTASIS=NO Confidence=100%, Support: ~9% = 7 cases Of course the findings are valid for the specific case-study that refers to a limited set of samples. Further evaluation and validation of results depends on the initiation of specific and targeted clinico-genomic trials that acquire adequate numbers of (statistically stratified) patients' samples. The running times for the discr-k_means and the ARM component of HealthObs were 13 and 3 seconds, respectively; the figures are indicative for the efficiency of the whole approach and of the respective clustering and ARM/HealthObs implementations.
Conclusions
We have presented a methodology for mining distributed and heterogeneous clinical and genomic data sources implemented within the context of the HealthObs environment. HealthObs represents an integrated platform with inter-operating software components that offers: (i) semantic homogenization of heterogeneous data resources, (ii) operationalization of ARM operations on-top of XML-formatted clinico-genomic data items, and (iii) flexible query-formulation and mining operations. Preliminary results on applying HealthObs on a real-world clinicogenomic (breast-cancer) study demonstrate the utility of the approach.
Our future research and development plans include: (a) design and development of appropriate human computer interfaces, accompanied with user-profiling capabilities for the personalized delivery of the results, (b) experimentation with other clinico-genomic domains and assessment of the clinical/genomic validity of the results, (c) incorporation of other data-mining operations (e.g., rule discovery), and (c) implementation of 'active-query' capabilities where, discovered clinico-genomic associations from pre-selected records are tested for potential differences and deviations so that, specific alarms could be broadcasted to the interested clinical researcher.
